Superrepression through Altered Corepressor-Activated Protein:Protein Interactions.
Chenlu HeGregory S CusterJingheng WangSilvina MatysiakDorothy BeckettPublished in: Biochemistry (2018)
Small molecules regulate transcription in both eukaryotes and prokaryotes by either enhancing or repressing assembly of transcription regulatory complexes. For allosteric transcription repressors, superrepressor mutants can exhibit increased sensitivity to small molecule corepressors. However, because many transcription regulatory complexes assemble in multiple steps, the superrepressor phenotype can reflect changes in any or all of the individual assembly steps. Escherichia coli biotin operon repression complex assembly, which responds to input biotin concentration, occurs via three coupled equilibria, including corepressor binding, holorepressor dimerization, and binding of the dimer to DNA. A genetic screen has yielded superrepressor mutants that repress biotin operon transcription in vivo at biotin concentrations much lower than those required by the wild type repressor. In this work, isothermal titration calorimetry and sedimentation measurements were used to determine the superrepressor biotin binding and homodimerization properties. The results indicate that, although all variants exhibit biotin binding affinities similar to that measured for BirAwt, five of the six superrepressors show altered homodimerization energetics. Molecular dynamics simulations suggest that the altered dimerization results from perturbation of an electrostatic network that contributes to allosteric activation of BirA for dimerization. Modeling of the multistep repression complex assembly for these proteins reveals that the altered sensitivity of the transcription response to biotin concentration is readily explained solely by the altered superrepressor homodimerization energetics. These results highlight how coupled equilibria enable alterations in a transcription regulatory response to input signal through an indirect mechanism.
Keyphrases
- transcription factor
- small molecule
- molecular dynamics simulations
- dna binding
- escherichia coli
- wild type
- cystic fibrosis
- gene expression
- binding protein
- pseudomonas aeruginosa
- high throughput
- genome wide
- staphylococcus aureus
- circulating tumor
- multidrug resistant
- molecular docking
- cell free
- protein protein
- candida albicans
- klebsiella pneumoniae
- circulating tumor cells